INVIVO THERAPEUTICS HOLDINGS CORP.
One Kendall Square
Suite B14402
Cambridge, Massachusetts 02139
November 13, 2019
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
|
Re: |
InVivo Therapeutics Holdings Corp. |
|
|
Registration Statement on Form S-3 |
|
|
File No. 333-234353 |
|
|
Request for Acceleration |
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, InVivo Therapeutics Holdings Corp. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-234353), so that it may become effective at 4:00 p.m. Eastern time on November 14, 2019, or as soon thereafter as practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff.
|
|
Very truly yours, | |
|
|
|
|
|
|
INVIVO THERAPEUTICS HOLDINGS CORP. | |
|
|
|
|
|
|
By: |
/s/ Richard Toselli |
|
|
Name: |
Richard Toselli |
|
|
Title: |
Chief Executive Officer |
cc: Rosemary G. Reilly
Wilmer Cutler Pickering Hale and Dorr LLP